Documentdetail
ID kaart

oai:pubmedcentral.nih.gov:1066...

Onderwerp
Research
Auteur
Eepho, Oony-Iye Bashir, Al-Amin M. Oniyide, Adesola A. Aturamu, Ayodeji Owolabi, Olutunmise V. Ajadi, Isaac O. Fafure, Adedamola A. Ajadi, Mary B. Areloegbe, Stephanie E. Olaniyi, Kehinde S.
Langue
en
Editor

BioMed Central

Categorie

BMC Neuroscience

Jaar

2023

vermelding datum

11-12-2023

Trefwoorden
plasma model hypothalamic butyrate pcos
Metriek

Beschrijving

Polycystic ovarian syndrome (PCOS) is a known endocrine disorder that has affected many women of childbearing age, and is accompanied by various neurodegenerative conditions.

Hence, this study investigates the impact of butyrate in reversing hypothalamic-related disorder, possibly through γ aminobutyric acid (GABA) in a rat model of PCOS.

Eight-week-old female Wistar rats were allotted into four groups (n = 5), which include control, butyrate, letrozole, and letrozole + butyrate groups.

PCOS was induced by administering 1 mg/kg of letrozole (oral gavage) for 21 days.

After confirmation of PCOS, 200 mg/kg of butyrate (oral gavage) was administered for 6 weeks.

Rats with PCOS were characterized by elevated levels of plasma insulin and testosterone.

Increases in plasma and hypothalamic triglyceride levels, inflammatory biomarker (SDF-1), apoptotic marker (caspase-6), and decreased plasma GnRH were observed.

Additionally, a decrease in hypothalamic GABA was revealed.

Nevertheless, the administration of butyrate attenuated these alterations.

The present study suggests that butyrate ameliorates hypothalamic inflammation in an experimental model of PCOS, a beneficial effect that is accompanied by enhanced GABA production.

Eepho, Oony-Iye,Bashir, Al-Amin M.,Oniyide, Adesola A.,Aturamu, Ayodeji,Owolabi, Olutunmise V.,Ajadi, Isaac O.,Fafure, Adedamola A.,Ajadi, Mary B.,Areloegbe, Stephanie E.,Olaniyi, Kehinde S., 2023, Modulation of GABA by sodium butyrate ameliorates hypothalamic inflammation in experimental model of PCOS, BioMed Central

Delen

Bron

Artikelen aanbevolen door ES/IODE AI

A rare case of localized peliosis hepatis during adjuvant chemotherapy including oxaliplatin mimicking a liver metastasis of colon cancer
peliosis hepatis metastatic liver tumor oxaliplatin oxaliplatin associated cancer metastatic tumor liver hepatis peliosis